MedPath

Takeda Pharmaceuticals International AG

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

SFDA:18
EMA:6

Drug Approvals

Fruzaqla

Authorization Status
Authorised
Approval Date
Jun 20, 2024
EMA

Intuniv

Authorization Status
Authorised
Approval Date
Sep 17, 2015
EMA

Revestive

Authorization Status
Authorised
Approval Date
Aug 30, 2012
EMA

Resolor

Authorization Status
Authorised
Approval Date
Oct 14, 2009
EMA

Firazyr

Authorization Status
Authorised
Approval Date
Jul 11, 2008
EMA

Xagrid

Authorization Status
Authorised
Approval Date
Nov 15, 2004
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.